The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors;L'utilità della 99mTc-tetrofosmina SPECT nella identificazione di metastasi del polmone da tumori primari extrapolmonari

Radiologia Medica

Volumn 107, Issue 1-2, 2004, Pages 113-127

  Spanu, Angela ^a   Solinas, Maria Elisabetta ^a   Farris, Antonio ^a   Arru, Antonio ^a   Chessa, Francesca ^a   Madeddu, Giordano ^a   Falchi, Antonio ^a   Madeddu, Giuseppe ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

99mTc tetrofosmin; Computed Tomography; Extrapulmonary primary tumors; Lung metastases; SPECT

Indexed keywords

FLUORODEOXYGLUCOSE; TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BRONCHOSCOPY; DIFFERENTIAL DIAGNOSIS; FEMALE; GASTROINTESTINAL CARCINOMA; HUMAN; IMAGE RECONSTRUCTION; LARYNX CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PROGNOSIS; RELIABILITY; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORACOTOMY; THYROID CARCINOMA; TUMOR LOCALIZATION; TUMOR RECURRENCE; UROGENITAL TRACT CANCER; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; EVALUATION; FOLLOW UP; LUNG; LUNG TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING; STATISTICAL ANALYSIS; TIME;

ADULT; AGED; BIOPSY, NEEDLE; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1542634839     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Scarantino CW, Omitz RD, Woodard SA: Metastases and Disseminated Disease. In: Philip Rubin (ed) Clinical Oncology 8th Edition, pag 845-863, WB Saunders, Philadelphia, 2001.
2. Pogrebniak HW, Haas G, Linehan WM: Renal cell carcinoma: resection of solitary and multiple metastases. Ann Thorac Surg 54: 33-38, 1992.
3. McAfee MK, Allen MS, Trastek VF et al: Colorectal lung metastases: results of surgical excision. Ann Thorac Surg 53: 780-785, 1992; discussion 785-786.
4. th Edition, pag 1102-1110, International Edition, McGraw-Hill, Inc., 1991.
5. Ren H, Hruban RH, Kuhlman JE et al: Computed tomography of inflation-fixed lungs: the beaded septum sign of pulmonary metastases. J Comput Assist Tomogr 13: 411-416, 1989.
6. Feuerstein IM, Jicha DL, Pass HI et al: Pulmonary metastases: MR imaging with surgical correlation- a prospective study. Radiology 182: 10-11, 1992.
7. Touliopoulos P, Costello P: Helical (spiral) CT of the thorax. Radiol Clin North Am 33: 843-861, 1995.
8. Herold CJ, Bankier AA, Fleischmann D: Lung metastases. Eur Radiol 6: 596-606, 1996.
9. Kersjes W, Mayer E, Buchenroth M et al: Diagnosis of pulmonary metastases with turbo-SE MR imaging. Eur Radiol 7: 1190-1194, 1997.
10. Lorenzen J, Beese M, Mester J et al: Chest X ray: routine indication in the follow-up of differentiated thyroid cancer? Nuklearmedizin 37: 208-212, 1998.
11. Webb WR, Gatsonis C, Zerhouni EA et al: CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 178: 705-713, 1991.
12. Patz EF Jr, Lowe VJ, Hoffman JM et al: Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 188: 487-490, 1993.
13. Duhaylongsod FG, Lowe VJ, Patz EJ et al: Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 110: 130-139, 1995.
14. Bury T, Dowlati A, Paulus P et al: Evaluation of the solitary pulmonary nodule by positron emission tomography imaging. Eur Respir J 9: 410-414, 1996.
15. Knight SB, Delbeke D, Stewart JR et al: Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 109: 982-988, 1996.
16. Lowe VJ, Duhaylongsod FG, Patz EF et al: Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology 202: 435-439, 1997.
17. Lowe VJ, Fletcher JW, Gobar L et al: Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 16: 1075-1084, 1998.
18. Gould MK, Maclean CC, Kuschner WG et al: Accuracy of positron emission tomography in the diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285: 914-924, 2001.
19. Rege SD, Hoh CK, Glaspy JA et al: Imaging of pulmonary mass lesions with whole body positron emission tomography and fluorodeoxyglucose. Cancer 72: 82-90, 1993.
20. Beets G, Penninckx F, Schiepers C et al: Clinical value of whole-body positron emission tomography with [18F]fluoro-deoxyglucose in recurrent colorectal cancer. Br J Surg 81: 1666-1670, 1994.
21. Boni R: Whole-body positron emission tomography: an accurate staging modality for metastatic melanoma. Arch Dermatol 132: 833-834, 1996.
22. Damian DL, Fulham MJ, Thompson E et al: Positron emission tomography in the detection and management of metastatic melanoma. Melanoma Res 6: 325-329, 1996.
23. Eigtved A, Andersson AP, Dahlstrøm et al: Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma. Eur J Nucl Med 27: 70-75, 2000.
24. Imdahl A, Reinhardt MJ, Nitzsche EU et al: Impact of 18F-FDG-positron emission tomography for decision making in coloiectal cancer recurrences. Langenbeck's Arch Surg 385: 129-134, 2000.
25. Hustinx R, Bénard F, Alavi A: Whole-Body FDG-PET Imaging in the management of patients with cancer. Semin Nucl Med 31: 35-46, 2002.
26. Hsu WH, Hsu NY, Shen YY et al: Differentiating solitary pulmonary metastases in patients with extrapulmonary neoplasms using FDG-PET. Cancer Invest. 21: 47-52, 2003.
27. Tonami N, Shuke N, Yokoyama K et al: Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 30: 997-1004, 1989.
28. Tonami N, Yokoyama K, Shuke N et al: Evaluation of suspected malignant pulmonary lesions with 201Tl single photon emission computed tomography. Nucl Med Commun 14: 602-610, 1993.
29. Chiti A, Schreiner FAG, Crippa F et al: Nuclear medicine procedures in lung cancer. Eur J Nucl Med 26: 533-555, 1999.
30. Kao CH, Wang SJ, Lin WY et al: Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 20: 249-254, 1993.
31. Bom HS, Kim YC, Song HC et al: Technetium-99m-MIBI uptake in small cell lung cancer. J Nucl Med 39: 91-94, 1998.
32. 99mTc-Tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging. Cancer Biother Radiopharm 15: 81-91, 2000.
33. 99mTc-Tetrofosmin SPET in both primary breast cancer and axillary lymph node metastasis detection. Eur J Nucl Med 28: 1781-1794, 2001.
34. Lind P, Gallowitsch HJ, Langsteger W et al: Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. J Nucl Med 38: 348-352, 1997.
35. Nishiyama Y, Yamamoto Y, Ono Y et al: Comparison of 99Tcm-tetrofosmin with 201T1 and 131I in the detection of differentiated thyroid cancer metastases. Nucl Med Commun 21: 917-923, 2000.
36. Choi JY, Kim SE, Shin HJ et al: Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201 T1, 99mTc-MIBI, and 18F-fluorodeoxyglucose. J Neurooncol 46: 63-70, 2000.
37. Alonso O, Martinez M, Mut F et al: Scintigraphic evaluation of malignant melanoma lesions with Tc-99m tetrofosmin. Clin Nucl Med 23: 683-685, 1998.
38. Lee JK, Tsai SC, Ho YJ et al: Technetium-99m tetrofosmin scintigraphy for detecting malignant lymphoma. Anticancer Res 21: 1509-1513, 2001.
39. Schillaci O, Monteleone F, D'Andrea N et al: Technetium-99m tetrofosmin single photon emission computed tomography in the evaluation of suspected lung cancer. Cancer Biother Radiopharm 14: 129-134, 1999.
40. 99m-TC-tetrofosmin scintigraphy in lung carcinoma staging and follow-up evaluations. Cancer 15: 1796-1807, 2002.
41. Shiun SC, Sun SS, Hsu NY et al: Detecting mediastinal lymph node metastases in non-small-cell-lung cancer using a combination of technetium-99m tetrofosmin chest single photon emission computed tomography and chest computed tomography. Cancer Invest 20: 311-317, 2002.
42. 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions. Int J Oncol 22: 639-649, 2003.
43. Schillaci O, Spanu A, Scopinaro F et al: Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with (99m)Tc-Tetrofosmin SPECT and comparison with CT. J Nucl Med 4: 1219-1224, 2003.
44. Kao CH, Changai SP, Shen YY et al: Technetium-99m-Tetrofosmin SPECT imaging of lung masses: a negative study. J Nucl Med 38: 1015-1018, 1997.
45. 99mTc-Tetrofosmin SPECT: comparison with [18F]FDG-PET. J Comput Assist Tomogr 24: 574-580, 2000.
46. 99mTc-furifosmin in human soft tissue sarcoma cell lines. Eur J Nucl Med 27: 1839-1843, 2000.
47. Arbab AS, Koizumi K, Toyama K et al: Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 37: 1551-1556, 1996.
48. 99mTc-Q12 in vitro and in vivo. Nucl Med Biol 25: 233-240, 1998.
49. Arbab AS, Koizumi K, Toyama K et al: Ion transport systems in the uptake of 99Tcm-tetrofosmin, 99Tcm-MIBI and 201 T1 in a tumor cell line. Nucl Med Commun 18: 235-240, 1997.
50. Higley B, Smith FW, Smith T et al: Technetium-99m-1,2bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 34: 30-38, 1993.
51. Spanu A, Farris A, Schillaci O et al: The usefulness of 99mTc tetrofosmin scintigraphy in patients with breast cancer recurrences. Nucl Med Commun 24: 145-154, 2003.
52. Spanu A, Solinas ME, Bagella C et al: The usefulness of Tc-99m Tetrofosmin (T) scan in the follow-up of differentiated thyroid carcinoma (DTC). J Nucl Med 3 (suppl): 236, 1997.
53. 99mTc-tetrofosmin SPECT in monitoring the response to chemotherapy in lung cancer patients. Oncol Rep 2003 (in press).
54. Kluetz PG, Meltzer CC, Villemagne VL et al: Combined PET/CT imaging in oncology. Impact on patient management. Clin Positron Imaging 3: 223-230, 2000.
55. Bar-Shalom R, Yefremov N, Guralnik L et al: Clinical Performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 44: 1200-1209, 2003.
56. Schillaci O, Danieli R, Manni C et al: The added clinical value of SPECT/CT with a hybrid imaging system. J Nucl Med 44 (suppl): 290 P, 2003.